Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Cancer Research
|
October 27, 1998
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression
R E Wilentz, J Geradts, R Maynard, et al.
The Journal of Pathology
|
December 18, 2001
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns
W Boecker, H Buerger, K Schmitz, et al.
Cancer Research
|
April 28, 2001
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
S Zöchbauer-Müller, K M Fong, A Maitra, et al.
British Journal of Cancer
|
October 14, 2005
Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York
G Varma, R Varma, H Huang, et al.
Radiology
|
March 14, 2000
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography
E D Pisano, R E Johnston, D Chapman, et al.
Cancer Research
|
August 1, 1997
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
M Schutte, R H Hruban, J Geradts, et al.
ESMO Open
|
March 11, 2026
TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer
S Jacob, E L Mayer, N Kacik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
A G Waks, O Cohen, B Kochupurakkal, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Cancer Research
|
October 27, 1998
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression
R E Wilentz, J Geradts, R Maynard, et al.
The Journal of Pathology
|
December 18, 2001
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns
W Boecker, H Buerger, K Schmitz, et al.
Cancer Research
|
April 28, 2001
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
S Zöchbauer-Müller, K M Fong, A Maitra, et al.
British Journal of Cancer
|
October 14, 2005
Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York
G Varma, R Varma, H Huang, et al.
Radiology
|
March 14, 2000
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography
E D Pisano, R E Johnston, D Chapman, et al.
Cancer Research
|
August 1, 1997
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
M Schutte, R H Hruban, J Geradts, et al.
ESMO Open
|
March 11, 2026
TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer
S Jacob, E L Mayer, N Kacik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
A G Waks, O Cohen, B Kochupurakkal, et al.
Page
of 6